Home Stock

Stock Research: LivaNova

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

LivaNova

NasdaqGS:LIVN GB00BYMT0J19
21
  • Value
    32
  • Growth
    69
  • Safety
    Safety
    21
  • Combined
    19
  • Sentiment
    30
  • 360° View
    360° View
    21
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

LivaNova PLC is a medical technology company. It operates in the medical technology industry, specifically in cardiopulmonary and neuromodulation. LivaNova PLC operates globally. In the last fiscal year, the company had a market cap of $2,368 million, profits of $871 million, revenue of $1,253 million, and 2900 employees.

more
Strongest Rank Dividend Yield
Weakest Rank Analyst Opinions
Country United Kingdom
Industry Health Care Equipment
Size Medium
Website livanova.comhome.action
Index
NASDAQ
S&P MIDCAP
LivaNova stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 30 27 27
Growth
69 26 59 57
Safety
Safety
21 46 54 6
Sentiment
30 56 29 42
360° View
360° View
21 21 27 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
79 85 56 83
Opinions Change
38 56 50 50
Pro Holdings
n/a n/a n/a n/a
Market Pulse
9 25 8 2
Sentiment
30 56 29 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 30 27 27
Growth
69 26 59 57
Safety Safety
21 46 54 6
Combined
19 9 35 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
67 13 1 20
Price vs. Earnings (P/E)
51 57 56 48
Price vs. Book (P/B)
43 71 68 59
Dividend Yield
1 1 1 1
Value
32 30 27 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
60 37 34 12
Profit Growth
60 55 70 70
Capital Growth
56 34 65 69
Stock Returns
75 30 39 61
Growth
69 26 59 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 56 54 36
Refinancing
33 83 73 9
Liquidity
8 12 14 10
Safety Safety
21 46 54 6

Similar Stocks

Discover high‑ranked alternatives to LivaNova and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Quilter

LSE:QLT
Country: United Kingdom
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Carl Zeiss Meditec

XTRA:AFX
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews